Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations.

IF 3.6 3区 医学 Q2 PHARMACOLOGY & PHARMACY Journal of clinical lipidology Pub Date : 2024-10-02 DOI:10.1016/j.jacl.2024.09.009
Justine Cole, Patrick Couture, André J Tremblay, Allan D Sniderman
{"title":"Variance in the composition and number of VLDL and LDL particles with increasing triglyceride or increasing ApoB concentrations.","authors":"Justine Cole, Patrick Couture, André J Tremblay, Allan D Sniderman","doi":"10.1016/j.jacl.2024.09.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The importance of any enhanced atherogenicity of triglyceride (TG)-rich lipoproteins (TRLs) will depend on the relative abundance of these particles compared with LDL or total apolipoprotein (apo)B. Accordingly, we determined the contribution that TRLs make to total apoB as TG or apoB concentrations increase. We also describe compositional changes in TRLs as TG or apoB increase to assess whether VLDL-C is a valid proxy for VLDL-apoB.</p><p><strong>Methods: </strong>We used sequential ultracentrifugation to separate lipoprotein fractions in plasma samples from 1940 dyslipidemic patients not on lipid-lowering medication, and measured apoB, cholesterol and TG in the plasma and in each subfraction. We analyzed this data in quartiles of TG or apoB.</p><p><strong>Results: </strong>There was wide variance in all parameters in all quartiles of both TG and apoB. Although VLDL-apoB accounted for almost all the increase in total apoB across TG quartiles, LDL-apoB still accounted for 80 % of the total in TG quartile 4. In contrast, LDL-apoB accounted for 90 % of the increase in apoB across apoB quartiles. As TG increases, the increase in VLDL-C is explained more by increased VLDL-C/apoB when TG is moderately elevated, and more by increased VLDL-apoB when TG is very high.</p><p><strong>Conclusions: </strong>In conclusion, VLDL-apoB only becomes a substantial component of total apoB with extreme hypertriglyceridemia and VLDL-C is not an appropriate proxy for VLDL-apoB.</p>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacl.2024.09.009","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The importance of any enhanced atherogenicity of triglyceride (TG)-rich lipoproteins (TRLs) will depend on the relative abundance of these particles compared with LDL or total apolipoprotein (apo)B. Accordingly, we determined the contribution that TRLs make to total apoB as TG or apoB concentrations increase. We also describe compositional changes in TRLs as TG or apoB increase to assess whether VLDL-C is a valid proxy for VLDL-apoB.

Methods: We used sequential ultracentrifugation to separate lipoprotein fractions in plasma samples from 1940 dyslipidemic patients not on lipid-lowering medication, and measured apoB, cholesterol and TG in the plasma and in each subfraction. We analyzed this data in quartiles of TG or apoB.

Results: There was wide variance in all parameters in all quartiles of both TG and apoB. Although VLDL-apoB accounted for almost all the increase in total apoB across TG quartiles, LDL-apoB still accounted for 80 % of the total in TG quartile 4. In contrast, LDL-apoB accounted for 90 % of the increase in apoB across apoB quartiles. As TG increases, the increase in VLDL-C is explained more by increased VLDL-C/apoB when TG is moderately elevated, and more by increased VLDL-apoB when TG is very high.

Conclusions: In conclusion, VLDL-apoB only becomes a substantial component of total apoB with extreme hypertriglyceridemia and VLDL-C is not an appropriate proxy for VLDL-apoB.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
VLDL 和 LDL 颗粒的组成和数量随甘油三酯或载脂蛋白 B 浓度增加而变化。
目的:富含甘油三酯(TG)的脂蛋白(TRLs)致动脉粥样硬化性增强的重要性取决于这些颗粒与低密度脂蛋白或总载脂蛋白(apo)B相比的相对丰度。因此,我们确定了随着 TG 或载脂蛋白 B 浓度的增加,TRL 对总载脂蛋白 B 的贡献。我们还描述了TRL随着TG或apoB增加而发生的成分变化,以评估VLDL-C是否是VLDL-apoB的有效替代物:我们使用顺序超速离心法分离了 1940 名未服用降脂药的血脂异常患者的血浆样本中的脂蛋白组分,并测量了血浆和每个亚组分中的载脂蛋白B、胆固醇和总胆固醇。我们以 TG 或载脂蛋白 B 的四分位数对这些数据进行了分析:结果:在 TG 和载脂蛋白 B 的所有四分位数中,所有参数的差异都很大。虽然 VLDL-apoB 几乎占了 TG 四分位数中载脂蛋白总量增加的全部,但在 TG 四分位数 4 中,LDL-apoB 仍占总量的 80%。相比之下,低密度脂蛋白-脂联素占载脂蛋白四分位数中载脂蛋白增加量的 90%。随着 TG 的增加,当 TG 中度升高时,VLDL-C 的增加更多地由 VLDL-C/apoB 的增加来解释,而当 TG 非常高时,VLDL-apoB 的增加则更多地由 VLDL-C/apoB 的增加来解释:总之,VLDL-apoB只有在极度高甘油三酯血症时才会成为总apoB的重要组成部分,而VLDL-C并不是VLDL-apoB的合适替代物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
6.80%
发文量
209
审稿时长
49 days
期刊介绍: Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
期刊最新文献
Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America. Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia. Falsely elevated triglyceride and lipase levels due to hyperglycerolemia in a burn patient treated with topical silver sulfadiazine. Complex dyslipidemia induced by Lorlatinib therapy: A case study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1